Quantcast

Subscribe to:
POZ magazine
E-newsletters
Join POZ: Facebook MySpace Twitter Pinterest
Tumblr Google+ Flickr MySpace
POZ Personals
Sign In / Join
Username:
Password:
Welcome, Guest. Please login or register.
July 26, 2014, 08:11:28 AM

Login with username, password and session length


Members
Stats
  • Total Posts: 631916
  • Total Topics: 47841
  • Online Today: 231
  • Online Ever: 585
  • (January 07, 2014, 02:31:47 PM)
Users Online

Welcome


Welcome to the POZ/AIDSmeds Community Forums, a round-the-clock discussion area for people with HIV/AIDS, their friends/family/caregivers, and others concerned about HIV/AIDS.  Click on the links below to browse our various forums; scroll down for a glance at the most recent posts; or join in the conversation yourself by registering on the left side of this page.

Privacy Warning:  Please realize that these forums are open to all, and are fully searchable via Google and other search engines. If you are HIV positive and disclose this in our forums, then it is almost the same thing as telling the whole world (or at least the World Wide Web). If this concerns you, then do not use a username or avatar that are self-identifying in any way. We do not allow the deletion of anything you post in these forums, so think before you post.

  • The information shared in these forums, by moderators and members, is designed to complement, not replace, the relationship between an individual and his/her own physician.

  • All members of these forums are, by default, not considered to be licensed medical providers. If otherwise, users must clearly define themselves as such.

  • Forums members must behave at all times with respect and honesty. Posting guidelines, including time-out and banning policies, have been established by the moderators of these forums. Click here for “Am I Infected?” posting guidelines. Click here for posting guidelines pertaining to all other POZ/AIDSmeds community forums.

  • We ask all forums members to provide references for health/medical/scientific information they provide, when it is not a personal experience being discussed. Please provide hyperlinks with full URLs or full citations of published works not available via the Internet. Additionally, all forums members must post information which are true and correct to their knowledge.

  • Product advertisement—including links; banners; editorial content; and clinical trial, study or survey participation—is strictly prohibited by forums members unless permission has been secured from POZ.

To change forums navigation language settings, click here (members only), Register now

Para cambiar sus preferencias de los foros en español, haz clic aquí (sólo miembros), Regístrate ahora

Finished Reading This? You can collapse this or any other box on this page by clicking the symbol in each box.

Author Topic: HCV Cure  (Read 960 times)

0 Members and 1 Guest are viewing this topic.

Offline Matts

  • Member
  • Posts: 205
HCV Cure
« on: March 27, 2013, 09:39:18 AM »
Am I allowed to post about HCV on AIDSmeds?
I think this study is interesting because some people are co-infected.
Gileadís sofosbuvir administered with BMSí daclatasvir reached a cure rate of nearly 100% in Phase II. Unfortunately Gilead doesn't want to work together with BMS any longer, maybe  doctors can prescribe these drugs separately as soon as they are approved, or Gilead's own Hepatitis Combo-Pill will be even better. :)

"High Rate of Sustained Virologic Response With the All-Oral Combination of Daclatasvir (NS5A Inhibitor) Plus Sofosbuvir (Nucleotide NS5B Inhibitor), With or Without Ribavirin, in Treatment-Naive Patients Chronically Infected With HCV GT 1, 2, or 3

Recent data from the Boston AASLD meeting confirm the spectacular Phase II combination results of Gileadís sofosbuvir administered with BMSí daclatasvir. (See results). These are truly amazing SVR rates which are much better than the current standard of care and without the use of the dreaded combination of interferon and ribavirin. Thousands of patients were so very hopeful about the possibility of quick access to this much more safe and effective, easily administered HCV drug combination.

How can Gilead Sciences in good conscience abandon a proven drug combination that has 100% cure rate in some patient populations with minimal side effects?  This combination has also shown to be safe in people with cirrhosis and a very real candidate for use in the liver transplant population. What is Gilead doing about providing early access to these very sick people who may actually die before Gilead completes the drug studies necessary for an all-Gilead combination regimen?...

http://hepc-cured.com/new-clinical-studies-high-rate-of-sustained-virologic-response-with-the-all-oral-combination-of-daclatasvir-plus-sofosbuvir-with-or-without-ribavirin/

http://www.hivandhepatitis.com/hepatitis-c/hepatitis-c-topics/hcv-treatment/3872-aasld-2012-sofosbuvir-daclatasvir-dual-regimen-cures-nearly-all-patients-with-hcv-genotypes-1-2-or-3
« Last Edit: March 27, 2013, 09:55:31 AM by Matts »
tivicay/kivexa

 


Terms of Membership for these forums
 

© 2014 Smart + Strong. All Rights Reserved.   terms of use and your privacy
Smart + Strong® is a registered trademark of CDM Publishing, LLC.